Serum gelsolin as a biomarker for differentiating familial Mediterranean fever from juvenile idiopathic arthritis in children
Serum-Gelsolin als Biomarker zur Differenzierung von familiärem Mittelmeerfieber und juveniler idiopathischer Arthritis bei Kindern
Biomolecules and Biomedicine · 04.05.2026 · 26 (10) · 1741-1750
DOI: 10.17305/bb.2026.13983 ↗Auf einen Blick
In einer prospektiven Fall-Kontroll-Studie waren die Serum-Gelsolinwerte bei Kindern mit familiärem Mittelmeerfieber höher als bei Kindern mit juveniler idiopathischer Arthritis und Kontrollen. Die Trennschärfe war gut (AUC 0,82).
Fragestellung
Eignet sich Serum-Gelsolin zur Differenzierung von familiärem Mittelmeerfieber und juveniler idiopathischer Arthritis bei Kindern?
Methode
Prospektive Fall-Kontroll-Studie bei 90 Kindern; Serum-Gelsolin per ELISA gemessen, klinische und Laborparameter analysiert.
Ergebnisse
90 Kinder im Alter von 2–18 Jahren: 30 mit JIA, 30 mit FMF, 30 Kontrollen. Serum-Gelsolin: 28,8 ± 2,5 bei FMF, 25,7 ± 2,8 bei JIA, 23,9 ± 2,7 bei Kontrollen; p < 0,001. AUC 0,82. OR 2,89 (95 %-KI 1,58–5,29) pro Einheit Gelsolin.
Schlussfolgerung der Autor:innen
Die Autor:innen schließen, dass Serum-Gelsolin ein wertvoller Biomarker in pädiatrischen inflammatorischen rheumatischen Erkrankungen sein könnte, besonders zur Differenzierung von FMF und JIA.
Kernaussagen
- FMF hatte die höchsten Serum-Gelsolinwerte
- AUC 0,82 für die Unterscheidung von FMF und JIA
- Gelsolin, AST und LDH waren unabhängige Prädiktoren
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules and Biomedicine, online erschienen am 04.05.2026. Verfasst von Esra Dişçi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Health and Diseases Clinic, Erzurum City Hospital, Erzurum, Türkiye. Hauptthemen laut MEDLINE: Gelsolin, Familial Mediterranean Fever, Arthritis, Juvenile. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Gelsolin (Gsn), an actin-binding protein implicated in cytoskeletal remodeling and the regulation of inflammation, has emerged as a potential biomarker for immune-mediated and inflammatory diseases. This prospective case-control study aimed to evaluate serum Gsn levels in children diagnosed with juvenile idiopathic arthritis (JIA) and familial Mediterranean fever (FMF) and to assess its potential utility in differentiating between these two pediatric rheumatic disorders. The study involved 90 children aged 2–18 years: 30 with JIA, 30 with FMF, and 30 age-matched healthy controls. Serum Gsn concentrations were quantified using enzyme-linked immunosorbent assay (ELISA), and both clinical and laboratory parameters were analyzed. Mean serum Gsn levels were highest in the FMF group (28.8 ± 2.5), followed by the JIA group (25.7 ± 2.8) and healthy controls (23.9 ± 2.7), with significant differences observed among the groups (p < 0.001). Gsn levels were significantly elevated in children with FMF compared to those with JIA, and receiver operating characteristic (ROC) analysis demonstrated strong discriminatory performance, with an area under the curve (AUC) of 0.82. Logistic regression analysis identified serum Gsn, aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) as independent predictors for distinguishing FMF from JIA. Each unit increase in Gsn was associated with increased odds of an FMF diagnosis (odds ratio [OR]: 2.89, 95% confidence interval [CI]: 1.58–5.29, p = 0.001). These findings suggest that serum Gsn may serve as a valuable biomarker in pediatric inflammatory rheumatic diseases, particularly in differentiating FMF from JIA. Further large-scale prospective studies are necessary to validate its diagnostic effectiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Health and Diseases Clinic, Erzurum City Hospital, Erzurum, Türkiye.
- Department of Pediatric Rheumatology, Marmara University Pendik Training and Research Hospital, Istanbul, Türkiye.
- Department of Physiology, Faculty of Medicine, Atatürk University, Erzurum, Türkiye.
- Department of Biostatistics, Faculty of Medicine, Atatürk University, Erzurum, Türkiye.
Zitieren
APA
Dişçi, E., Adrovic Yıldız, A., Özbek Şebin, S., & Kaşali, K. (2026). Serum gelsolin as a biomarker for differentiating familial Mediterranean fever from juvenile idiopathic arthritis in children. Biomolecules and Biomedicine, 26(10), 1741-1750. https://doi.org/10.17305/bb.2026.13983
Vancouver
Dişçi E, Adrovic Yıldız A, Özbek Şebin S, Kaşali K. Serum gelsolin as a biomarker for differentiating familial Mediterranean fever from juvenile idiopathic arthritis in children. Biomolecules and Biomedicine. 2026;26(10):1741-1750. doi:10.17305/bb.2026.13983
BibTeX
@article{Dii2026,
author = {Dişçi, Esra and Adrovic Yıldız, Amra and Özbek Şebin, Saime and Kaşali, Kamber},
title = {Serum gelsolin as a biomarker for differentiating familial Mediterranean fever from juvenile idiopathic arthritis in children},
journal = {Biomolecules and Biomedicine},
year = {2026},
volume = {26},
number = {10},
pages = {1741--1750},
doi = {10.17305/bb.2026.13983}
}
EUVIMED